Project title: Project MICRO ID-19 - Development of a consortium of MICRO-organisms as supporting therapy for COVID-19

 

Project code: ALT20-03-02B7-FEDER-069744

​

Main objective: To develop a consortium of intestinal microorganisms to be administered as an adjunctive immunomodulatory therapy for COVID-19, allowing to improve the immune response of individuals against Sars-Cov-2 and to avoid or reduce the severity of COVID-19.

 

Intervention region: Alentejo

 

Beneficiary: MyBiome, Lda

 

 

Approved on : 09/07/2020

 

Start date: 22/09/2020

 

Completion date: 06/21/2021

 

Total eligible cost: € 398,837.35

​

European Union financial support: ERDF - 365 642,35 €

​

 

​

​